We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Real-world analysis reports outcomes in relapse and refractory multiple myeloma patients, indicating differences in BCMA therapy histories.
No takes yet. Share an insight, caveat, or question.
Samour et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: